Sort   by:  
 Page size 
UnknownA phase I study of BMS-690514 in Japanese patients with advanced or metastatic solid tumors.
Not available
S-EPMC3456941 | biostudies-literature
UnknownA Phase I, dose-finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors.
Not available
S-EPMC7713608 | biostudies-literature
UnknownPharmacokinetic profiles of significant adverse events with crizotinib in Japanese patients with ABCB1 polymorphism.
Not available
S-EPMC4982581 | biostudies-literature
UnknownPhase I study for ridaforolimus, an oral mTOR inhibitor, in Japanese patients with advanced solid tumors.
Not available
S-EPMC3313018 | biostudies-literature
UnknownPhase 1 and dose-finding study of patritumab (U3-1287), a human monoclonal antibody targeting HER3, in Japanese patients with advanced solid tumors.
Not available
S-EPMC3931937 | biostudies-literature
UnknownClinical trends among patients with asthma hospitalized for COVID-19 based on data from a nationwide database: an observational study
Not available
S-EPMC10909272 | biostudies-literature
UnknownS-1 eliminates MDSCs and enhances the efficacy of PD-1 blockade via regulation of tumor-derived Bv8 and S100A8 in thoracic tumor.
Not available
S-EPMC9899614 | biostudies-literature
UnknownEfficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusion.
Not available
S-EPMC9158359 | biostudies-literature
UnknownPhase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors.
Not available
S-EPMC5352798 | biostudies-literature
UnknownComparative efficacy of biologics for uncontrolled asthma patients with chronic rhinosinusitis or nasal polyps: a systematic review and network meta-analysis.
Not available
S-EPMC12486953 | biostudies-literature
Sort   by:  
 Page size